Equities research analysts expect Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT – Get Rating) to report earnings of ($0.13) per share for the current quarter, Zacks reports. Two analysts have made estimates for Calumet Specialty Products Partners’ earnings, with the lowest EPS estimate coming in at ($0.64) and the highest estimate coming in at $0.17. Calumet Specialty Products Partners posted earnings per share of ($0.97) during the same quarter last year, which suggests a positive year-over-year growth rate of 86.6%. The company is scheduled to announce its next earnings results on Monday, January 1st.
On average, analysts expect that Calumet Specialty Products Partners will report full year earnings of ($1.43) per share for the current year, with EPS estimates ranging from ($1.81) to ($1.24). For the next year, analysts forecast that the firm will post earnings of $1.36 per share, with EPS estimates ranging from $1.22 to $1.52. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side analysts that that provide coverage for Calumet Specialty Products Partners.
Calumet Specialty Products Partners (NASDAQ:CLMT – Get Rating) last announced its quarterly earnings data on Friday, May 6th. The oil and gas company reported ($0.87) EPS for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.31). The business had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $870.80 million. During the same period in the previous year, the business earned ($1.82) earnings per share.
A number of institutional investors have recently bought and sold shares of CLMT. Acadian Asset Management LLC purchased a new position in Calumet Specialty Products Partners during the fourth quarter worth about $42,000. Worth Asset Management LLC purchased a new position in Calumet Specialty Products Partners during the first quarter worth about $54,000. Covestor Ltd purchased a new position in shares of Calumet Specialty Products Partners in the 1st quarter worth about $77,000. Dorsey Wright & Associates boosted its holdings in shares of Calumet Specialty Products Partners by 15.7% in the 4th quarter. Dorsey Wright & Associates now owns 9,014 shares of the oil and gas company’s stock worth $119,000 after purchasing an additional 1,224 shares in the last quarter. Finally, Future Financial Wealth Managment LLC purchased a new position in shares of Calumet Specialty Products Partners in the 4th quarter worth about $120,000. Institutional investors and hedge funds own 25.70% of the company’s stock.
Shares of NASDAQ:CLMT traded down $0.13 during mid-day trading on Tuesday, hitting $12.83. 115,573 shares of the company traded hands, compared to its average volume of 178,323. The stock has a market cap of $1.02 billion, a P/E ratio of -4.95 and a beta of 2.15. Calumet Specialty Products Partners has a 12-month low of $5.40 and a 12-month high of $17.43. The stock has a 50-day moving average price of $13.70 and a two-hundred day moving average price of $14.25.
Calumet Specialty Products Partners Company Profile (Get Rating)
Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products.
- Get a free copy of the StockNews.com research report on Calumet Specialty Products Partners (CLMT)
- Zoom Video Communications Is Primed To Launch Higher
- Fundamental Strength Makes Williams-Sonoma One for Your Recovery Watchlist
- Institutions Buy The Dip In Petco Health and Wellness Company
- Veeva Systems: Increasing NDR and Other Wins
- Autozone Edges Past Advanced Auto Parts In Q1 2022
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.